Quanane en es it fr

Quanane Brand names, Quanane Analogs

Quanane Brand Names Mixture

  • No information avaliable

Quanane Chemical_Formula


Quanane RX_link

No information avaliable

Quanane fda sheet

Quanane msds (material safety sheet)

Quanane Synthesis Reference

No information avaliable

Quanane Molecular Weight

309.469 g/mol

Quanane Melting Point

< 25 oC

Quanane H2O Solubility

Soluble as HCl salt

Quanane State


Quanane LogP


Quanane Dosage Forms

Tablets (oral, 1 mg)

Quanane Indication

Used for the symptomatic treatment of parkinsonism.

Quanane Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Quanane Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Quanane side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Quanane Patient Information

Quanane Organisms Affected

Humans and other mammals